Ignoring the obvious question of how anyone could create a “vaccine” for a metabolic disease, Russia has said it’s done it and it’ll be available this fall. The new cancer vaccine is a personalized treatment designed to target malignant tumors using the patient’s own genetic information. If cancer is truly a metabolic disease, as science is discovering, then how can a “vaccine” prevent it? According to Alexander Gintsburg, head of the Gamaleya Research Institute of Epidemiology and Microbiology, as cited by TASS, Russian cancer patients will begin receiving the vaccine this fall. The last big announcement of an mRNA vaccine was the one created to combat COVID-19 under the United States’ Operation Warp Speed.